BALTIMORE--(BUSINESS WIRE)--March 30, 2006--BRT Laboratories, Inc. Has Been Contracted by OncoMethylome Sciences, to Perform MGMT Methylation Assays for a Multi-Site, International Clinical Trial. BRT Laboratories, Inc. announced today that they have entered into a collaboration to provide molecular testing services to OncoMethylome Sciences in an ongoing international clinical trial. BRT is utilizing assay technology from OncoMethylome Sciences that measures the methylation status of the MGMT gene in patients.
